• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Gkb Share Price

    Gkb Ophthalmics Share PriceGKB Ophthalmics

    Small Cap 2.9k Result
    ₹99.00
    -0.84 (-0.84%)
    As on 27 September, 2023 | 10:53 BSE: 533212 NSE: GKBISIN: INE265D01015

    Gkb Ophthalmics Performance

    Day Range

    • Low 84
    • High 90.9
    99.00

    52 Week Range

    • Low 0
    • High 90.9
    99.00
    • Open Price84.5
    • Previous Close88.4
    • Volume83081

    Start SIP in GKB Ophthalmics

    Start SIP

    Gkb Ophthalmics Share Price

    • Over 1 Month 10.12%
    • Over 3 Month 6.74%
    • Over 6 Month -11.49%
    • Over 1 Year -8.63%

    Gkb Ophthalmics Key Statistics

    P/E Ratio -31.6
    PEG Ratio 0.2
    Market Cap Cr 50
    Price to Book Ratio 0.7
    EPS -5.8
    Dividend 0
    Relative Strength Index 55.63
    Money Flow Index 80.91
    MACD Signal 3.1
    Average True Range 5.98

    Gkb Ophthalmics Investment Rating

    • Master Rating:

    • Gkb Ophthalmics has an operating revenue of Rs. 79.90 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 0% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 9% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 11 which is a POOR score indicating inconsistency in earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 108 indicates it belongs to a poor industry group of Medical-Products and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    GKB Ophthalmics Financials
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 1067787
    Operating Expenses Qtr Cr 978777
    Operating Profit Qtr Cr 1-1-1010
    Depreciation Qtr Cr 120001
    Interest Qtr Cr 000000
    Tax Qtr Cr 000000
    Net Profit Qtr Cr 0-20-10-1
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 3029
    Operating Expenses Annual Cr 2927
    Operating Profit Annual in Cr -10
    Depreciation Cr 32
    Interest Annual Cr 11
    Tax Annual Cr 00
    Net Profit Annual Cr -3-2
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr -12
    Cash from Investing Activity Annual Cr 2-1
    Cash from Financing Annual Activity Cr -2-1
    Net Cash Flow Annual Cr -10
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 2830
    Fixed Assets Annual Cr 2125
    Total Non Current Assets Annual Cr 3640
    Total Current Assets Annual Cr 1314
    Total Assets Annual Cr 4954
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 5560
    ROE Annual % -10-8
    ROCE Annual % -5-3
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 46
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 222019191817
    Operating Expenses Qtr Cr 212019171516
    Operating Profit Qtr Cr 100232
    Depreciation Qtr Cr 120001
    Interest Qtr Cr 000000
    Tax Qtr Cr 000000
    Net Profit Qtr Cr 1-2-1121
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 7672
    Operating Expenses Annual Cr 7266
    Operating Profit Annual in Cr 45
    Depreciation Cr 33
    Interest Annual Cr 21
    Tax Annual Cr 00
    Net Profit Annual Cr 01
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr -35
    Cash from Investing Activity Annual Cr 1-4
    Cash from Financing Annual Activity Cr -2-2
    Net Cash Flow Annual Cr -40
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 6363
    Fixed Assets Annual Cr 2326
    Total Non Current Assets Annual Cr 2935
    Total Current Assets Annual Cr 8476
    Total Assets Annual Cr 112110
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 134134
    ROE Annual % 02
    ROCE Annual % 35
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 68

    Gkb Ophthalmics Technicals

    EMA & SMA

    Current Price
    ₹99.00
    -0.84 (-0.84%)
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹98.05
    • 50 Day
    • ₹94.99
    • 100 Day
    • ₹97.22
    • 200 Day
    • ₹101.39
    • 20 Day
    • ₹98.01
    • 50 Day
    • ₹91.27
    • 100 Day
    • ₹94.88
    • 200 Day
    • ₹109.71

    Gkb Ophthalmics Resistance and Support

    PIVOT
    ₹99.6
    Resistance
    First Resistance ₹102.19
    Second Resistance ₹104.54
    Third Resistance ₹107.13
    RSI 55.63
    MFI 80.91
    MACD Single Line 3.1
    MACD 2.69
    Support
    First Resistance ₹97.25
    Second Resistance ₹94.66
    Third Resistance ₹92.31

    Gkb Ophthalmics Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 2,193 154,102 70.27
    Week 2,259 165,201 73.13
    1 Month 7,670 575,061 74.98
    6 Month 6,982 534,391 76.54

    Gkb Ophthalmics Result Highlights

    GKB Ophthalmics Synopsis

    BSE-Medical-Products

    Gkb Ophthalmic is involved in the business activities of Manufacture of ophthalmic goods, eyeglasses, sunglasses, lenses ground to prescription, contact lenses, safety goggles etc.. Company’s Total Operating Revenue is Rs. 27.73 Cr. and Equity Capital is Rs. 5.04 Cr. for the Year ended 31/03/2023. GKB Ophthalmics Ltd. is a Public Limited Listed company incorporated on 10/12/1981 and has its registered office in the State of Goa, India. Company’s Corporate Identification Number(CIN) is L26109GA1981PLC000469 and registration number is 000469.
    Market Cap 50
    Sales 30
    Shares in Float 0.21
    No of funds 2
    Yield
    Book Value 1.83
    U/D Vol ratio 1.9
    LTDebt / Equity 4
    Alpha 0.1
    Beta 0.67

    GKB Ophthalmics

    Owner NameJun-23Mar-23Dec-22Sep-22
    Promoters 59.18%59.09%59.09%59.16%
    Foreign Portfolio Investors 1.79%1.79%1.98%1.98%
    Individual Investors 27.39%27.11%24.8%24.82%
    Others 11.64%12.01%14.13%14.04%

    GKB Ophthalmics Management

    Name Designation
    Mr. K G Gupta Chairman & Managing Director
    Mr. Vikram Gupta Director
    Mr. Anil Palekar Director
    Mr. Subhash Redkar Director
    Mrs. Shashi Kumar Katreddi Director

    Gkb Ophthalmics Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Gkb Ophthalmics Corporate Action

    Date Purpose Remarks
    2023-08-11 Quarterly Results
    2023-05-30 Audited Results
    2023-02-14 Quarterly Results
    2022-08-12 Quarterly Results
    2022-05-30 Audited Results
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    GKB Ophthalmics FAQs

    What is Share Price of GKB Ophthalmics ?

    GKB Ophthalmics share price is ₹99 As on 27 September, 2023 | 10:39

    What is the Market Cap of GKB Ophthalmics ?

    The Market Cap of GKB Ophthalmics is ₹49.9 Cr As on 27 September, 2023 | 10:39

    What is the P/E ratio of GKB Ophthalmics ?

    The P/E ratio of GKB Ophthalmics is -31.6 As on 27 September, 2023 | 10:39

    What is the PB ratio of GKB Ophthalmics ?

    The PB ratio of GKB Ophthalmics is 0.7 As on 27 September, 2023 | 10:39

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.